Literature DB >> 33826817

Preparing for the Future - Nanobodies for Covid-19?

Ram Sasisekharan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33826817     DOI： 10.1056/NEJMcibr2101205

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  14 in total

1.  Engineered single-domain antibodies tackle COVID variants.

Authors:  James E Voss
Journal:  Nature       Date:  2021-07       Impact factor: 49.962

2.  Anti-viral treatment for SARS-CoV-2 infection: A race against time amidst the ongoing pandemic.

Authors:  Natalia G Vallianou; Dimitrios Tsilingiris; Gerasimos Socrates Christodoulatos; Ιrene Karampela; Maria Dalamaga
Journal:  Metabol Open       Date:  2021-05-25

Review 3.  Overview of Neutralizing Antibodies and Their Potential in COVID-19.

Authors:  José Javier Morales-Núñez; José Francisco Muñoz-Valle; Paola Carolina Torres-Hernández; Jorge Hernández-Bello
Journal:  Vaccines (Basel)       Date:  2021-11-23

Review 4.  Central Nervous System Delivery of Antibodies and Their Single-Domain Antibodies and Variable Fragment Derivatives with Focus on Intranasal Nose to Brain Administration.

Authors:  Arghavan Soleimanizadeh; Heiko Dinter; Katharina Schindowski
Journal:  Antibodies (Basel)       Date:  2021-11-30

5.  Allosteric Determinants of the SARS-CoV-2 Spike Protein Binding with Nanobodies: Examining Mechanisms of Mutational Escape and Sensitivity of the Omicron Variant.

Authors:  Gennady Verkhivker
Journal:  Int J Mol Sci       Date:  2022-02-16       Impact factor: 5.923

Review 6.  Aptamers as promising nanotheranostic tools in the COVID-19 pandemic era.

Authors:  Christian K O Dzuvor; Ebenezer Larteh Tettey; Michael K Danquah
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2022-03-03

7.  Hetero-bivalent nanobodies provide broad-spectrum protection against SARS-CoV-2 variants of concern including Omicron.

Authors:  Huan Ma; Xinghai Zhang; Peiyi Zheng; Peter H Dube; Weihong Zeng; Shaohong Chen; Qingyu Cheng; Yunru Yang; Yan Wu; Junhui Zhou; Xiaowen Hu; Yan Xiang; Huajun Zhang; Sandra Chiu; Tengchuan Jin
Journal:  Cell Res       Date:  2022-07-29       Impact factor: 46.297

Review 8.  Nanobodies as powerful pulmonary targeted biotherapeutics against SARS-CoV-2, pharmaceutical point of view.

Authors:  Ali Najmeddin; Mina Bahrololoumi Shapourabadi; Mahdi Behdani; Farid Dorkoosh
Journal:  Biochim Biophys Acta Gen Subj       Date:  2021-07-31       Impact factor: 3.770

Review 9.  Bovine-derived antibodies and camelid-derived nanobodies as biotherapeutic weapons against SARS-CoV-2 and its variants: A review article.

Authors:  AbdulRahman A Saied; Asmaa A Metwally; Moses Alobo; Jaffer Shah; Khan Sharun; Kuldeep Dhama
Journal:  Int J Surg       Date:  2022-01-19       Impact factor: 6.071

Review 10.  Structural and Computational Studies of the SARS-CoV-2 Spike Protein Binding Mechanisms with Nanobodies: From Structure and Dynamics to Avidity-Driven Nanobody Engineering.

Authors:  Gennady Verkhivker
Journal:  Int J Mol Sci       Date:  2022-03-08       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.